Evidence map›Paper›PMID 33342544›Full record

ArticleBiological psychiatry2021

Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder.

Brittany D Needham, Mark D Adame, Gloria Serena, Destanie R Rose, Gregory M Preston, Mary C Conrad, A Stewart Campbell, David H Donabedian, Alessio Fasano, Paul Ashwood and 1 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06915805 (BABY@NET), which is not on this map. Cited by 154 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
154citing papers in PubMed, 1 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06915805 recruitingnot on this mapstarted 2023, after this paper: background citation

BABY@NET: A Technology-based National Surveillance Network for the Early Identification of Autism Spectrum Disorder and Other Neurodevelopmental Disorders in At-risk Populations

TypeobservationalSponsorIstituto Superiore di SanitàRan2023 to 2025Enrolled296ConditionsAutism Spectrum Disorder (ASD), Neurodevelopmental Disorders
3 · Its place in the literature

Who cites it

154 citing papers in PubMed, 1 synthesis or guideline pooled it, 228 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

94 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Brittany D NeedhamDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California. Electronic address: bneedham@caltech.edu.
Mark D AdameDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California.
Gloria SerenaDivision of Pediatric Gastroenterology and Nutrition, Mucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Boston, Massachusetts.
Destanie R RoseDepartment of Medical Microbiology and Immunology, University of California, Davis, Davis, California; MIND Institute, University of California, Davis, Sacramento, California.
Gregory M PrestonAxial Biotherapeutics, Waltham, Massachusetts.
Mary C ConradAxial Biotherapeutics, Waltham, Massachusetts.
A Stewart CampbellAxial Biotherapeutics, Waltham, Massachusetts.
David H DonabedianAxial Biotherapeutics, Waltham, Massachusetts.
Alessio FasanoDivision of Pediatric Gastroenterology and Nutrition, Mucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Boston, Massachusetts.
Paul AshwoodDepartment of Medical Microbiology and Immunology, University of California, Davis, Davis, California; MIND Institute, University of California, Davis, Sacramento, California.
Sarkis K MazmanianDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California. Electronic address: sarkis@caltech.edu.
Nanotherapeutics (United States) · USCalifornia Institute of Technology · USBoston Children's Hospital · USUniversity of California Davis Medical Center · US

Funding

Investigating the Gut Microbiome for Novel Therapies and Diagnostics for AutismR01MH100556 · NIMH · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MAZMANIAN, SARKIS K · 2013 to 2017
$2.8M
Immune regulation and gastrointestinal co-morbidity in autism spectrum disordersR01HD090214 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ASHWOOD, PAUL · 2018 to 2022
$1.9M
NICHD NIH HHS R01 HD090214NIMH NIH HHS R01 MH100556
6 · The paper itself

Abstract

backgroundAutism spectrum disorder (ASD) is a neurodevelopmental condition with hallmark behavioral manifestations including impaired social communication and restricted repetitive behavior. In addition, many affected individuals display metabolic imbalances, immune dysregulation, gastrointestinal dysfunction, and altered gut microbiome compositions.

methodsWe sought to better understand nonbehavioral features of ASD by determining molecular signatures in peripheral tissues through mass spectrometry methods (ultrahigh performance liquid chromatography-tandem mass spectrometry) with broad panels of identified metabolites. Herein, we compared the global metabolome of 231 plasma and 97 fecal samples from a large cohort of children with ASD and typically developing control children.

resultsDifferences in amino acid, lipid, and xenobiotic metabolism distinguished ASD and typically developing samples. Our results implicated oxidative stress and mitochondrial dysfunction, hormone level elevations, lipid profile changes, and altered levels of phenolic microbial metabolites. We also revealed correlations between specific metabolite profiles and clinical behavior scores. Furthermore, a summary of metabolites modestly associated with gastrointestinal dysfunction in ASD is provided, and a pilot study of metabolites that can be transferred via fecal microbial transplant into mice is identified.

conclusionsThese findings support a connection between metabolism, gastrointestinal physiology, and complex behavioral traits and may advance discovery and development of molecular biomarkers for ASD.

Indexed as

Autism Spectrum DisorderGastrointestinal MicrobiomeAnimalsFecesMicePilot ProjectsPlasmaASDAutism spectrum disorderFecal metabolitesMetabolomicsMitochondrial dysfunctionPhenolic metabolitesPlasma metabolitesSteroid hormones

Identifiers

PMID33342544
PMCPMC7867605
OpenAlexW3092166226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.